Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Journal of Bacteriology|September 6, 2006
Hypoxanthine incorporation is nonmutagenic in Escherichia coliBrian Budke, Andrei KuzminovMolecular Microbiology|December 1, 2009
Production of clastogenic DNA precursors by the nucleotide metabolism in Escherichia coliBrian Budke, Andrei KuzminovChemmedchem|October 27, 2016
Recent Developments Using Small Molecules to Target RAD51: How to Best Modulate RAD51 for Anticancer Therapy?Brian Budke, Wei Lv, Alan P Kozikowski, et al.Nucleic Acids Research|May 14, 2013
Real-time solution measurement of RAD51- and RecA-mediated strand assimilation without background annealingBrian Budke, Yuen-Ling Chan, Douglas K Bishop, et al.Journal of Medicinal Chemistry|April 7, 2016
Development of Small Molecules that Specifically Inhibit the D-loop Activity of RAD51Wei Lv, Brian Budke, Michal Pawlowski, et al.Chemmedchem|April 9, 2019
Optimization of Drug Candidates That Inhibit the D-Loop Activity of RAD51Brian Budke, Werner Tueckmantel, Kelsey Miles, et al.Science (New York, N.Y.)|September 8, 2012
Rad51 is an accessory factor for Dmc1-mediated joint molecule formation during meiosisVeronica Cloud, Yuen-Ling Chan, Jennifer Grubb, et al.Nucleic Acids Research|November 8, 2025
Mei5-Sae3 stabilizes both active and inactive forms of Dmc1 filaments independently of its impact on ATP hydrolysisYuen-Ling Chan, Diedre Reitz, Brian Budke, et al.Nucleic Acids Research|June 11, 2022
Noncanonical NF-κB factor p100/p52 regulates homologous recombination and modulates sensitivity to DNA-damaging therapyBrian Budke, Alison Zhong, Katherine Sullivan, et al.Journal of Medicinal Chemistry|December 13, 2012
An optimized RAD51 inhibitor that disrupts homologous recombination without requiring Michael acceptor reactivityBrian Budke, Jay H Kalin, Michal Pawlowski, et al.Pageof 2